Announced details
Glaucoma treatment
The patent is expected to extend the product's life cycle, but the quantitative impact is Not disclosed
A product created and under development by the company. The patent holder is D.Western Therapeutics Institute, Inc.
The agency serving as Singapore's patent office (official name: Not disclosed)
Application number 11202105739Y. The patent has received a decision to grant; registration of the patent and establishment of the patent rights are expected after payment of the patent fee. Validity period: Not disclosed
No changes have been made to the earnings forecast for the fiscal year ending December 2026
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Glaucoma treatment "H-1337" |
| Relationship with the Company | A product created and under development by the company. The patent holder is D.Western Therapeutics Institute, Inc. |
| Applicable area | Glaucoma treatment |
| Awarding / certifying body | The agency serving as Singapore's patent office (official name: Not disclosed) |
| Registration number and expiry date | Application number 11202105739Y. The patent has received a decision to grant; registration of the patent and establishment of the patent rights are expected after payment of the patent fee. Validity period: Not disclosed |
| Quantitative Effects | The patent is expected to extend the product's life cycle, but the quantitative impact is Not disclosed |
| Impact on Business Performance | No changes have been made to the earnings forecast for the fiscal year ending December 2026 |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explains that, as part of life cycle management for "H-1337," the patent is expected to extend the product's life cycle and will be beneficial for future expansion into various countries and broader commercialization of the product.